Valerie Berry
Family · Huntsville, ALNPI 1962879189
Payments from drug & device makers
Across 482 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$1K
- AstraZeneca$724
- Novo Nordisk$494
- Lilly USA, LLC$445
- Bayer$412
- plus $3K from 36 others
What the payments were for
- Food & beverage$7,51999%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,604 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 77 | $130,650 |
| JardianceEmpagliflozin | 112 | $115,670 |
| LinzessLinaclotide | 120 | $114,056 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 96 | $110,381 |
| OzempicSemaglutide | 82 | $108,252 |
| EliquisApixaban | 86 | $66,857 |
| VraylarCariprazine Hcl | 34 | $62,042 |
| FarxigaDapagliflozin Propanediol | 62 | $54,155 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 45 | $46,591 |
| JanuviaSitagliptin Phosphate | 63 | $44,026 |
| MyrbetriqMirabegron | 59 | $40,281 |
| XareltoRivaroxaban | 29 | $38,687 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $31,140 |
| RybelsusSemaglutide | 18 | $31,092 |
| Nurtec OdtRimegepant Sulfate | 12 | $27,144 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Vraylar | $1,843 | $176,098154 claims |
| Lilly USA, LLCMounjaro, Trulicity | $445 | $153,58894 claims |
| Novo NordiskOzempic, Rybelsus | $494 | $139,344100 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $196 | $133,266136 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,043 | $130,373131 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $724 | $105,897127 claims |
| PfizerEliquis, Nurtec Odt, Prempro | $324 | $97,285112 claims |
| MerckJanuvia | $22 | $44,02663 claims |
| Astellas Pharma US IncMyrbetriq | $99 | $40,28159 claims |
| Johnson & JohnsonXarelto | $41 | $38,68729 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $102 | $24,22527 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $40 | $9,91714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Huntsville
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Julia BettsHuntsville$27K
- Joann IkardHuntsville$19K
- Hannah GarnettHuntsville$18K
- Alyssa FikesHuntsville$15K
- Justin WilsonCullman$1.1M
- Molly ReevesAuburn$158K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.